Schedule 13G ownership disclosure

Ligand Pharmaceuticals Inc

Common Stock · CUSIP: 53220K504

Event date: 2025-03-31

Filing-level shares
1,028,066
Percent of class
5.3%
  • JANUS HENDERSON GROUP PLC

    Shares: 1,028,066 · Class: 5.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001274173-25-000165
Form type
SCHEDULE 13G/A
Filer
Janus Henderson Group Ltd.
CIK
CIK 1274173
Filed
May 14, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub